Vyne Therapeutics Inc and Yarrow Bioscience Merger Conference Call Transcript
Good morning and welcome to the Vyne Therapeutics conference call to discuss the merger of Vyne and Yarrow Bioscience. This call is being recorded for replay at the company's request.
It's now my pleasure to turn the call over to John Fraunces, Director of Corporate Communications for LifeSci Advisors. Please go ahead, John.
Good morning and thank you for joining us for today's conference call. The link to this webcast is on the investors page of the Vyne Therapeutics Corporate website.
Before we begin, I would like to remind you that our call today will include remarks about future expectations, plans, and prospects for Vyne and Yarrow, which constitute forward-looking statements for the purpose of the safe harbor provisions under applicable federal securities laws.
These forward-looking statements include, without limitation, statements regarding the proposed merger and other contemplated transactions. These forward-looking statements involve significant risks and uncertainties that could
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
